Symmetry Medical (SMA) Reports Q1 In-Line
Symmetry Medical (NYSE: SMA) reports Q1 EPS of $0.19 versus the analyst estimate of $0.19. Revenue for the quarter was $101.4 million, versus the consensus of $98.33 million.
Click Here To Try StreetInsider's LIVE NEWS FEED for FREE for a limited time! http://www.streetinsider.com/premium_content.php
Related Categories
EarningsStocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
